IN CYTU, INC.
LINCOLN, RI, 02865-4257
|# of Employees:||0|
|Socially and Economically Disadvantaged:||N|
DESCRIPTION provided by applicant A Phase II SBIR program of preclinical development is proposed for the development of an active specific immunotherapeutic called Cellariumandquot for treatment o ...SBIRPhase II2016Department of Health and Human Services
DESCRIPTION (provided by applicant): A Phase I SBIR program of preclinical development is proposed focusing on the development of an active specific immunotherapeutic called Cellarium for treatm ...SBIRPhase I2010Department of Health and Human Services